Source/Disclosures
Disclosures: Beck reports no relevant financial disclosures.
May 26, 2020
1 min read
Save

Patient satisfaction after hip arthroscopy can be determined with VAS

Source/Disclosures
Disclosures: Beck reports no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patient satisfaction with clinical outcomes at 2 years after hip arthroscopy for femoroacetabular impingement syndrome is largely due to preoperative alpha angles and BMI, according to published results.

Researchers at the department of orthopedic surgery at Rush University Medical Center set out to define substantial clinical benefit (SCB), patient acceptable symptomatic state (PASS) and minimal clinically important difference (MCID) for VAS satisfaction.

According to the study abstract, selection criteria consisted of patients who underwent primary hip arthroscopy to address femoroacetabular impingement syndrome that was clinically and radiographically confirmed and had at least 2 years of follow-up.

Three hundred thirty-five patients were included in the final analysis, and VAS satisfaction values were set at 52.8 for MCID, 80.9 for PASS and 89.7 for SCB.

“The rates of achieving clinically significant improvement on the VAS satisfaction was 85.6%, 68.1%, and 56.9% for MCID, PASS, and SCB, respectively. A larger preoperative alpha angle was predictive for achieving SCB (odds ratio [OR], 1.076; P = .046), whereas lower BMI (OR, 0.955; P = .047) and larger preoperative alpha angle (OR, 1.12; P = .025) were predictors for achieving PASS,” the researchers wrote in the abstract.

Researchers deemed patient satisfaction could effectively be measured by the VAS. Additionally, they concluded that preoperative variables including larger preoperative alpha angle and lower BMI are predictors of achieving superior clinical satisfaction. – by Max R. Wursta

Disclosure: Beck reports no relevant financial disclosures.